3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Non-Small-Cell Lung
17
Carcinoma, Hepatocellular
8
Nasopharyngeal Carcinoma
7
Recurrence
6
Neoplasms
6
Esophageal Neoplasms
6
Breast Neoplasms
6
Stomach Neoplasms
5
Neoplasm Metastasis
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Locally Advanced Rectal Cancer
4
Carcinoma, Renal Cell
4
Urinary Bladder Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Rectal Neoplasms
3
Melanoma
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Hyperthermia
2
Chondrosarcoma
2
Carcinoma, Transitional Cell
2
Interventions
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Adenoviridae Infections
×
Immune Checkpoint Inhibitors
×
Clear all
NCT04673942
2024-10-26
BETA-PRIME
EpicentRx, Inc.
Phase 2
Recruiting
140 enrolled